The BSE Sensex fell by 372.46 points or 0.69% to close at
53,514.15, extending its walling streak to the third day. The index opened
higher and hit the day’s high of 54,211 amid gains in Asian markets. However,
it failed to hold onto its gains and dropped over 750 points to touch a low of
53,455.26 as European markets started lower. The NSE Nifty declined 91.65 points or 0.57% to settle
below the 16,000 level at 15,966.65.

The broader indices ended in green with the BSE Mid cap
index up by 0.32%, while the Small cap index was up by 0.04%. On the sectoral
front, Healthcare was up by 0.97%, FMCG was up by 0.85%, Metal was up by 0.83%,
Basic Materials were up by 0.69% and Consumer Disc up was by 0.25%, while
Utilities down by 1.71%, Power down by 1.71%, Oil & Gas down by 1.43%,
Energy down by 1.26% and Telecom down by 1.07% were the top losing indices on
BSE.

Here are the key stocks that moved the most on July 13:

HCL Technologies: The stock price ended 1.01% down at Rs
918.40 after the IT firm reported a 2.11% growth in its consolidated profit
after tax at Rs 3,281 crore, against Rs 3,213 crore reported in the year-ago
period. Sequentially, the profit declined by 8.83% from Rs 3,599 crore in the
March quarter.

IndusInd Bank: The share price fell 3.13% to close at Rs
820.50. The Enforcement Directorate (ED) has been investigating a few entities
inter alia for certain alleged irregularities in remittances for import transactions
conducted from 2011 to 2014. The bank had suo motto filed Suspicious
Transaction Reports with the regulatory authorities during the relevant period
for many of these entities. The bank had also filed complaints with police in
2015 against some of the unscrupulous entities.

CARE Ratings: The stock ended 12.42% higher at Rs 466.50
after the company in its BSE filing said the Board of Directors on July 20 will
consider a proposal for the buyback of equity shares of the company.

Mindtree: The stock price jumped 2.01% to close at Rs 2,911
after the company reported a 0.3% in net profit to Rs 471.6 crore against Rs
473.1 crore in the previous quarter. In rupee terms, revenue surged 7.7% at Rs
3,121.1 crore against Rs 2,897.4 crore in the March quarter. 

Shilpa Medicare: The share price surged 4.97% to close at
Rs 416 after the company’s newly commissioned facility for the manufacturing
and testing of orodispersible films and transdermal systems, situated at
Dabaspet near Bengaluru, has been issued a GMP certificate by the UK’s
Medicines and Healthcare Products Regulatory Agency.